NCT05692830
Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Aug 1, 2026 to Sep 5, 2026
- Site details revised
- Publications: details revised at 25 of 27 entries
- Minor Study description expanded, about 38 wordsv6
- Minor Site contact updated
- Study description expanded, about 5 words
- Notable Start date: Apr 3, 2022 to Oct 22, 2022v4
- Notable Phase: Not applicable to Not specified
- Primary endpoints: 2 to 3
- Study description expanded, about 12 words
- Study arms: 2 to 0
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Transdermal estimates of alcohol consumption
Timeframe: Across the 14 day period of the study
Transdermal estimates of drinking risk level
Timeframe: Across the 14 day period of the study
Transdermal estimates of blood alcohol concentration
Timeframe: Across the 14 day period of the study
Arms and interventions
Drugs: Alcohol
Sites
1 site in 1 country
- University of Illinois at Urbana-ChampaignChampaign, Illinois, United States